UPDATED RESULTS OF A MULTICENTER PHASE I/IB STUDY OF TGR-1202 IN COMBINATION WITH IBRUTINIB IN PATIENTS WITH RELAPSED OR REFRACTORY MCL OR CLL
Davids, M.S., Kim, H.T., Nicotra, A., Savell, A., Francoeur, K., Hellman, J.M., Miskin, H., Sportelli, P., Bashey, A., Stampleman, L., Rueter, J., Boruchov, A., Arnason, J.E., Jacobson, C.A., JacobsenVolume:
35
Language:
english
Journal:
Hematological Oncology
DOI:
10.1002/hon.2437_39
Date:
June, 2017
File:
PDF, 134 KB
english, 2017